Details for New Drug Application (NDA): 091392
✉ Email this page to a colleague
The generic ingredient in METOCLOPRAMIDE HYDROCHLORIDE is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
Summary for 091392
Tradename: | METOCLOPRAMIDE HYDROCHLORIDE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | metoclopramide hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 091392
Mechanism of Action | Dopamine D2 Antagonists |
Medical Subject Heading (MeSH) Categories for 091392
Suppliers and Packaging for NDA: 091392
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | INJECTABLE;INJECTION | 091392 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1367 | 51662-1367-1 | 1 SYRINGE, GLASS in 1 BLISTER PACK (51662-1367-1) / 2 mL in 1 SYRINGE, GLASS |
METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | INJECTABLE;INJECTION | 091392 | ANDA | Fresenius Kabi USA, LLC | 76045-101 | 76045-101-20 | 24 BLISTER PACK in 1 CARTON (76045-101-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-101-00) / 2 mL in 1 SYRINGE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 5MG BASE/ML | ||||
Approval Date: | Apr 19, 2013 | TE: | AP | RLD: | No |
Complete Access Available with Subscription